Literature DB >> 17396576

Inhibition of migration of monocytes and granulocytes in vivo by the peptide corresponding to sequence 65-76 of monocyte chemotactic protein-1 (MCP-1).

E I Chazov1, T L Krasnikova, Z D Bespalova, N B Kukhtina, M G Melekhov, T I Aref'eva, M V Sidorova, A S Molokoedov, T E Gvozdik, B M Mart'yanov, V V Pozdeev, V B Sergienko, T L Bushueva.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17396576     DOI： 10.1134/s1607672906060044

Source DB:  PubMed          Journal:  Dokl Biochem Biophys        ISSN： 1607-6729            Impact factor:   0.788


× No keyword cloud information.
  14 in total

Review 1.  Chemokines: immunology's high impact factors.

Authors:  C R Mackay
Journal:  Nat Immunol       Date:  2001-02       Impact factor: 25.606

2.  [Peptide fragments and structural analogues of chemokine MPC-1: synthesis and effect on the MPC-1-induced migration of monocytes].

Authors:  M B Sidorova; A S Molokoedov; T I Aref'eva; N B Kukhtina; T L Krasnikova; Zh D Bespalova; V N Bushuev
Journal:  Bioorg Khim       Date:  2004 Nov-Dec

3.  The peptide of sequence 66-77 of monocytic chemotactic protein (MCP-1) inhibits inflammation in experimental animals.

Authors:  T L Krasnikova; T I Arefieva; M G Melekhov; N B Kukhtina; M V Sidorova; A S Molokoedov; V N Bushuev; Zh D Bespalova; E I Chazov
Journal:  Dokl Biol Sci       Date:  2005 Sep-Oct

Review 4.  Chemokines.

Authors:  B J Rollins
Journal:  Blood       Date:  1997-08-01       Impact factor: 22.113

5.  [Antibodies against synthetic peptide fragments of T-cadherin inhibit binding of low density proteins with T-cadherin].

Authors:  M V Sidorova; A S Molokoedov; A A Az'muko; D V Stambol'skiĭ; N M Kashirina; V N Bochkov; V A Tkachuk; Zh D Bespalova
Journal:  Bioorg Khim       Date:  1999-03

Review 6.  Chemokines and atherosclerosis.

Authors:  T J Reape; P H Groot
Journal:  Atherosclerosis       Date:  1999-12       Impact factor: 5.162

7.  Structural diversity of heparan sulfate binding domains in chemokines.

Authors:  Hugues Lortat-Jacob; Aurélien Grosdidier; Anne Imberty
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-05       Impact factor: 11.205

8.  The heparin/heparan sulfate-binding site on apo-serum amyloid A. Implications for the therapeutic intervention of amyloidosis.

Authors:  J B Ancsin; R Kisilevsky
Journal:  J Biol Chem       Date:  1999-03-12       Impact factor: 5.157

Review 9.  Chemokine inhibition--why, when, where, which and how?

Authors:  Z Johnson; C A Power; C Weiss; F Rintelen; H Ji; T Ruckle; M Camps; T N C Wells; M K Schwarz; A E I Proudfoot; C Rommel
Journal:  Biochem Soc Trans       Date:  2004-04       Impact factor: 5.407

10.  Identification of the glycosaminoglycan binding site of the CC chemokine, MCP-1: implications for structure and function in vivo.

Authors:  Elaine K Lau; Chad D Paavola; Zoë Johnson; Jean-Philippe Gaudry; Elena Geretti; Frédéric Borlat; Andreas J Kungl; Amanda E Proudfoot; Tracy M Handel
Journal:  J Biol Chem       Date:  2004-03-18       Impact factor: 5.157
View more
  2 in total

1.  Synthetic peptide fragment (65-76) of monocyte chemotactic protein-1 (MCP-1) inhibits MCP-1 binding to heparin and possesses anti-inflammatory activity in stable angina patients after coronary stenting.

Authors:  T I Arefieva; T L Krasnikova; A V Potekhina; N U Ruleva; P I Nikitin; T I Ksenevich; B G Gorshkov; M V Sidorova; Zh D Bespalova; N B Kukhtina; S I Provatorov; E A Noeva; E I Chazov
Journal:  Inflamm Res       Date:  2011-07-10       Impact factor: 4.575

2.  Effect of the C-terminal domain peptide fragment (65-76) of monocytic chemotactic protein-1 (MCP-1) on the interaction between MCP-1 and heparin.

Authors:  T L Krasnikova; P I Nikitin; T I Ksenevich; B G Gorshkov; A V Orlov; M V Sidorova; A A Azmuko; T I Arefieva; E N Mamochkina; E E Efremov; Zh D Bespalova
Journal:  Dokl Biol Sci       Date:  2010-08-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.